Gaussian

Equity Research Monitor

Lokman Hekim

The latest in enterprise and strategic research are at your fingertips below, summarized in Gaussian's research monitor.

Lokman Hekim - Potential New Acquisition to add 200 bed capacity

Lokman Hekim - Potential New Acquisition to add 200 bed capacity

Lokman have had a busy quarter with investor events. Expect more in 2H18. Both trading and investments appear on track to meet guidance.

Read More

Lokman Hekim 2020 results and outlook

Lokman Hekim 2020 results and outlook

Lokman have had a busy quarter with investor events. Expect more in 2H18. Both trading and investments appear on track to meet guidance.

Read More

HYSET by Lokman Hekim - the 21st Century Care with Price Transparency on Offer

HYSET by Lokman Hekim - the 21st Century Care with Price Transparency on Offer

Her Yerde Saglik ve Elektronik Ticaret A.S. (HYSET), a wholly-owned subsidiary of Lokman Hekim, operates a marketplace for healthcare services where patients match their needs with products and packages the network hospitals have on offer.

Read More

GEM Healthcare - HYSET, Lokman Hekim's Venture in MedTech

GEM Healthcare - HYSET, Lokman Hekim's Venture in MedTech

Lokman has invested in a medical technology company to establish an exclusive online marketplace for healthcare services. Her Yerde Saglik ve Elektronik Ticaret A.S. (HYSET) is a wholly-owned subsidiary of Lokman. The medical marketplace helps patients match their needs and requirements with services available in the network.

Read More

GEM Healthcare - Lokman Hekim on track to meet guidance

GEM Healthcare - Lokman Hekim on track to meet guidance

Lokman have had a busy quarter with investor events. Expect more in 2H18. Both trading and investments appear on track to meet guidance.

Read More

GEM Healthcare - Lokman reports recovery in EPS with risks now to the upside

GEM Healthcare - Lokman reports recovery in EPS with risks now to the upside

Lokman Hekim 3Q17 results beat street estimates. The earnings available for shareholders read TL1.6M versus a net loss of TL0.8M reported in June quarter. There is significant scope to benefit from operating leverage; the risks are now tilted towards the upside.

Read More